Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 5595  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (177 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Acknowledgments
 ::  References
 ::  Article Figures

 Article Access Statistics
    Viewed3036    
    Printed47    
    Emailed0    
    PDF Downloaded139    
    Comments [Add]    

Recommend this journal


 


 
LETTER
Year : 2007  |  Volume : 53  |  Issue : 4  |  Page : 273-274

A massive myxoid liposarcoma with hyperferritinemia


1 Hope Hospital, Salford, Lancashire, United Kingdom
2 Geriatrics and General Medicine, North West Region, United Kingdom
3 Stepping Hill Hospital, Stockport, Lancashire, United Kingdom

Correspondence Address:
R Fletcher
Hope Hospital, Salford, Lancashire
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0022-3859.37524

Rights and Permissions




How to cite this article:
Fletcher R, Raw J, Datta-Chaudhury M. A massive myxoid liposarcoma with hyperferritinemia. J Postgrad Med 2007;53:273-4

How to cite this URL:
Fletcher R, Raw J, Datta-Chaudhury M. A massive myxoid liposarcoma with hyperferritinemia. J Postgrad Med [serial online] 2007 [cited 2019 Nov 21];53:273-4. Available from: http://www.jpgmonline.com/text.asp?2007/53/4/273/37524


Sir,

Liposarcomas are one of the most common sarcomas of adulthood. The following case discusses a gentleman who presented with a massive abdominal myxoid liposarcoma associated with significant hyperferritinemia. We present the case and a discussion of hyperferritinemia and neoplasms, with reference to the potential of ferritin as a marker of disease recurrence.

A gentleman of 82 years of age presented with epigastric pain. Initial investigations were unremarkable except for a serum ferritin of 1542 ng/ml. An ultrasound scan was performed, which showed a large complex cystic mass in the epigastrium slightly to the left of the midline, containing echogenic material with thickened walls and septae in parts [Figure - 1]. A repeat serum ferritin assay was 2190 ng/ml. All other routine blood tests were again unremarkable. The patient wanted no further investigations. Six months later in June of the following year he developed acute abdominal pain. A CT scan at that time revealed a mass 30 x 30 cm with calcification within it. It displaced the colon around it and engulfed the stomach and duodenum. The patient underwent a laparotomy and the huge mass was resected. Histology later confirmed the mass to be a myxoid liposarcoma with clear resection margins and no involvement of surrounding organs [Figure - 2].

He was reviewed in the outpatients department four months after surgery. His serum ferritin had returned to the normal range. He failed to attend further outpatient follow-up appointments and contact was lost with him. Two years later the patient presented acutely with a palpable lump at the site of his previous laparotomy scar. This was shown to be a local recurrence of the myxoid liposarcoma in the subcutaneous tissue of his abdominal wall [Figure - 3], rather than a metastasis and was associated once more with a rise in serum ferritin to 1687 ng/ml that could not otherwise be accounted for. However, he refused any further intervention and preferred to be left alone with no further follow-up. He has not re-presented to the hospital and is still thought to be alive.

Of the soft tissue sarcomas, liposarcomas are the most common in adults. The most recent World Health Organization classification of soft tissue tumors recognizes five categories of liposarcomas: (1) well-differentiated; (2) dedifferentiated; (3) myxoid; (4) round cell; and (5) pleomorphic. Diagnosis is often late in retroperitoneal liposarcomas after the tumor has reached considerable size. Symptoms tend to not develop until other abdominal organs are being affected, with pain being the predominant symptom. The mainstay of treatment is surgical resection by wide local excision, which provides the best outcomes. Local recurrence is common however. Low-grade liposarcomas including myxoid tumors have the lowest metastatic potential, this justifies repeated resections for local recurrences. [1]

Hyperferritinemia has been reported on several occasions in patients with neoplastic disease. Significantly high serum ferritin levels have been found in patients with breast cancer; among this group there was also a significant correlation with increased serum ferritin and lymph node involvement. [2] Other research has shown correlation between serum ferritin levels and the clinical stage and bulk of breast tumors. [3] Pinto et al. examined preoperative levels of ferritin in patients with epithelial ovarian cancer and found that the mean serum concentration was significantly elevated compared to a control group. Positive correlation was also noted between ferritin levels and advancing disease stage. [4] Serum ferritin levels may also be a useful marker for diagnosing and staging renal cell carcinoma (RCC). Miyata et al., investigated a link between preoperative serum ferritin and tumor stage in RCC. It was concluded that elevated serum levels of ferritin might be suggestive of distant metastases. [5] Furthermore a study by Milman and Pedersen concluded that serum levels of ferritin have prognostic value in patients with primary lung cancer, even after adjustment for confounding factors. [6]

In this case, the serum ferritin appears to be a marker for the tumor. To this date, we can find no previously reported case of a very high serum ferritin associated with any type of liposarcoma, which returned to normal following resection of the tumor and rose again with recurrence. It may be that serum ferritin could be used in some cases to assess the possibility of recurrence of liposarcoma during follow-up.


 :: Acknowledgments Top


The authors wish to thank the staff of the histopathology lab at Stepping Hill and Dr. Kate Morgan, Consultant Histopathologist, Stepping Hill Hospital, Stockport.

 
 :: References Top

1.Neuhaus SJ, Barry P, Clark MA, Hayes AJ, Fisher C, Thomas JM. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg 2005;92:246-52.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Ulbrich EJ, Lebrecht A, Schneider I, Ludwig E, Koelbl H, Hefler LA. Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res 2003;23:5107-9.  Back to cited text no. 2  [PUBMED]  
3.Kher A, Moghe G, Deshpande A. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast. Indian J Pathol Microbiol 1997;40:321-6.  Back to cited text no. 3  [PUBMED]  
4.Pinto V, Marinaccio M, Garofalo S, Vittoria Larocca AM, Geusa S, Lanzilotti G, et al . Preoperative evaluation of ferritinemia in primary epithelial ovarian cancer. Tumori 1997;83:927-9.  Back to cited text no. 4  [PUBMED]  
5.Miyata Y, Koga S, Nishikido M, Hayashi T, Kanetake H. Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma. BJU Int 2001;88:974-7.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]
6.Milman N, Pedersen LM. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol Rep 2002;9:193-8.  Back to cited text no. 6  [PUBMED]  


    Figures

  [Figure - 1], [Figure - 2], [Figure - 3]



 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow